Skip to content
![Patient-derived organoids as a reliable screening platform for assessing ADC efficacy and specificity]()
April 29, 2024
Patient-derived organoids as a reliable screening platform for assessing ADC efficacy and specificity
read more
![Resistant PDO models: Unraveling drug resistance mechanisms for discovering new drug targets]()
April 29, 2024
Resistant PDO models: Unraveling drug resistance mechanisms for discovering new drug targets
read more
![Patient-derived organoids: A pre-clinical model to assess infection and killing capacity of viral vectors for cancer therapy]()
April 29, 2024
Patient-derived organoids: A pre-clinical model to assess infection and killing capacity of viral vectors for cancer therapy
read more
![Developing a patient-derived organoid biobank, suitable for large-scale drug screenings]()
May 15, 2023
Developing a patient-derived organoid biobank, suitable for large-scale drug screenings
read more
![Developing a patient-derived bladder cancer organoid biobank suitable for large-scale drug screenings]()
January 16, 2023
Developing a patient-derived bladder cancer organoid biobank suitable for large-scale drug screenings
read more
![Development of a medium-to-high throughput organoid and bacteria co-culture platform for the assessment of host-pathogen interaction]()
January 16, 2023
Development of a medium-to-high throughput organoid and bacteria co-culture platform for the assessment of host-pathogen interaction
read more
![Patient in the lab: predicting clinical responses using patient-derived organoid screening]()
June 3, 2022
Patient in the lab: predicting clinical responses using patient-derived organoid screening
read more
